We are live on ! Find out more
SBIO icon

ALPS Medical Breakthroughs ETF
SBIO

70 hedge funds and large institutions have $79M invested in ALPS Medical Breakthroughs ETF in 2021 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 21 increasing their positions, 12 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

355% more call options, than puts

Call options by funds: $2.61M | Put options by funds: $573K

75% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 12

44% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 9

7% more capital invested

Capital invested by funds: $74M → $79M (+$5M)

4% more funds holding

Funds holding: 67 → 70 (+3)

1.98% more ownership

Funds ownership: 28.9% → 30.88% (+2%)

Holders
70
Holders Change
+3
Holders Change %
+4.48%
% of All Funds
1.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
21
Reduced
12
Closed
9
Calls
$2.61M
Puts
$573K
Net Calls
+$2.04M
Net Calls Change
+$394K

Top Buyers

Rank Fund Capital Flow
1
PF
Phoenix Financial
Israel
+$4.71M
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$1.6M
3
Ameriprise
Ameriprise
Minnesota
+$1.4M
4
FEM
Fulcrum Equity Management
Texas
+$1.37M
5
CCP
Cardan Capital Partners
Colorado
+$901K

Top Sellers

Rank Fund Capital Flow
1
NL
NWAM LLC
Washington
-$2.25M
2
Citadel Advisors
Citadel Advisors
Florida
-$1.17M
3
VNA
Valley National Advisers
Pennsylvania
-$958K
4
Wells Fargo
Wells Fargo
California
-$524K
5
CT
Cambridge Trust
Massachusetts
-$323K
Name Holding Trade Value Shares
Change 		Change in
Stake
GAM
26
Griffin Asset Management
New York
$458K – – –
SIC
27
SFE Investment Counsel
California
$451K -$103K -1,869 -17%
Cetera Investment Advisers
28
Cetera Investment Advisers
Illinois
$424K +$43.5K +785 +10%
MC
29
Matisse Capital
Oregon
$373K – – –
RA
30
RFG Advisory
Alabama
$338K – – –
EWA
31
Exencial Wealth Advisors
Oklahoma
$325K +$13.1K +237 +4%
CCC
32
Crescent Capital Consulting
Louisiana
$302K – – –
SWP
33
Stratos Wealth Partners
Ohio
$287K -$20.5K -370 -6%
UCFA
34
United Capital Financial Advisors
Texas
$246K – – –
Envestnet Asset Management
35
Envestnet Asset Management
Illinois
$235K +$259K +4,683 New
VNA
36
Valley National Advisers
Pennsylvania
$226K -$958K -17,301 -79%
BPCE
37
Bank Pictet & Cie (Europe)
Germany
$221K +$244K +4,400 New
KFGK
38
Keystone Financial Group (Kentucky)
Kentucky
$206K – – –
PGFC
39
Peapack-Gladstone Financial Corp
New Jersey
$201K – – –
Rockefeller Capital Management
40
Rockefeller Capital Management
New York
$201K – – –
AWM
41
AllSquare Wealth Management
New York
$188K +$23K +415 +12%
Northwestern Mutual Wealth Management
42
Northwestern Mutual Wealth Management
Wisconsin
$85K +$65.7K +1,186 +237%
KPCM
43
Kings Point Capital Management
New York
$80K – – –
ACA
44
Atlas Capital Advisors
Wyoming
$70.4K +$77.5K +1,400 New
US Bancorp
45
US Bancorp
Minnesota
$50K – – –
EWM
46
Elmwood Wealth Management
California
$50K +$55.4K +1,000 New
CFD
47
Creative Financial Designs
Indiana
$38K +$11.1K +200 +36%
CAPTRUST Financial Advisors
48
CAPTRUST Financial Advisors
North Carolina
$28K – – –
JP Morgan Chase
49
JP Morgan Chase
New York
$26K +$28.2K +509 New
APA
50
American Portfolios Advisors
New York
$23.5K – – –
1
2
3 4

SBIO Hedge Fund Activity: Q1 2021 in Review

70 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q1 2021, worth a combined $79M — up 6.8% from $74M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new SBIO positions and 9 closed out — a net gain of 4 holders — while 21 added to existing stakes and 12 trimmed.

The largest buyer was Phoenix Financial, opening a new position worth an estimated $4.71M. The largest seller was NWAM LLC, exiting entirely with an estimated $2.25M sold.

  • 70 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q1 2021, up from 67 in Q4 2020.
  • Funds reported $79M of ALPS Medical Breakthroughs ETF stock for Q1 2021, up 6.8% quarter-over-quarter.
  • 13 funds opened new ALPS Medical Breakthroughs ETF positions in Q1 2021 and 9 closed out, a net change of +4 holders.
  • The largest ALPS Medical Breakthroughs ETF buyer in Q1 2021 was Phoenix Financial, an estimated $4.71M added.
  • The largest ALPS Medical Breakthroughs ETF seller in Q1 2021 was NWAM LLC, an estimated $2.25M sold.

Based on aggregated 13F filings for Q1 2021.